|
|
|
|
 |
|
SENSEX
|
 |
112.35
|
0.49%
|
|
23114.50
|
|
|
|
NIFTY
|
 |
325.72
|
0.44%
|
|
74532.96
|
|
|
|
Nasdaq
|
 |
-443.08
|
-2.01%
|
|
21647.61
|
|
|
|
Nikkei 225
|
 |
-1866.87
|
-3.38%
|
|
53372.53
|
|
|
|
FTSE 100
|
 |
-145.17
|
-1.44%
|
|
9918.33
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cipla |
|
BSE Code |
500087
|
|
ISIN Demat |
INE059A01026
|
|
Book Value (Rs) |
419.19
|
|
|
NSE Code |
CIPLA
|
|
Dividend Yield % |
1.27
|
|
Market Cap (Rs) |
1014453.82
|
|
|
TTM PE(x) |
21.98
|
|
TTM EPS(Rs) |
57.14
|
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
17-08 1935
|
|
Registered Office
|
Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra-400013 .
|
|
ISINNO
|
INE059A01026
|
|
Phone
|
022-24826000
|
|
E-mail
|
contactus@cipla.com |
|
URL
|
www.cipla.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Y K Hamied
|
|
Managing Director
|
Umang Vohra
|
|
Company Secretary
|
Rajendra Chopra
|
|
Listing
|
BSE,NSE,Luxembourg
|
|
|
|
|
|
|
|
|
|
|
|